Legal Representation
Attorney
H MATHEWS GARLAND
USPTO Deadlines
Application History
9 events| Date | Code | Type | Description |
|---|---|---|---|
| Nov 19, 1999 | ABN2 | O | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
| Mar 11, 1999 | CNFR | O | FINAL REFUSAL MAILED |
| Jan 25, 1999 | DOCK | D | ASSIGNED TO EXAMINER |
| Dec 29, 1998 | DOCK | D | ASSIGNED TO EXAMINER |
| Dec 12, 1998 | DOCK | D | ASSIGNED TO EXAMINER |
| Dec 7, 1998 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| May 14, 1998 | DOCK | D | ASSIGNED TO EXAMINER |
| May 14, 1998 | CNRT | F | NON-FINAL ACTION MAILED |
| May 6, 1998 | DOCK | D | ASSIGNED TO EXAMINER |
Detailed Classifications
Class 005
pharmaceutical preparations and substances for the use in the treatment of heart disease; microcapsules and microspheres containing diagnostic reagents reagents or drugs for pharmaceutical use, namely, for introduction to the body of introduction to the body of drugs, genes, and other therapeutic products or diagnostic reagents for medical clinical use; pharmaceutical preparations and substances for use in the delivery of drugs, genes, other therapeutic products, namely, antibiotics, anti-inflammatories, diagnostic reagents, and anti-cancer drugs, or diagnostic reagents for medical clinical use, all for use in the treatment of heart disease
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005